Allogeneic CAR-T Cells Show Promise in Refractory Lupus Cases
A recent study published in Cell Reports Medicine explores the safety and preliminary efficacy of allogeneic CD19-targeted CAR-T cell therapy in patients with severe systemic lupus erythematosus (SLE). Conducted between August and October 2023, the study involved three individuals with multi-organ involvement and disease that had not responded to conventional therapies. Participants received a single […]